Mereo BioPharma Group plc
MREO
$0.24
$0.00-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.66% | 51.94% | -13.42% | -82.90% | 53.02% |
| Total Depreciation and Amortization | 5,481.82% | -103.69% | 10.37% | -1.46% | -2.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 296.29% | -108.97% | 56.39% | 237.00% | -140.86% |
| Change in Net Operating Assets | -661.50% | 147.45% | -64.01% | -159.98% | 162.06% |
| Cash from Operations | -5.10% | 4.47% | 8.14% | 11.58% | -25.28% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -- | 100.00% | -- | -- |
| Cash from Investing | -100.00% | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -106.15% | -62.50% | 93.27% |
| Cash from Financing | -- | 100.00% | -131.75% | 1,155.00% | 93.27% |
| Foreign Exchange rate Adjustments | 84.93% | -129.29% | 57.16% | 172.06% | -204.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.76% | -16.81% | 13.13% | 31.73% | -55.16% |